144P Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3)
Title:
144P Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3)
Author:
Fasching, P. Neven, P. Jerusalem, G. Beck, J.T. Chan, A. De Laurentiis, M. Bianchi, G.V. Martin Jimenez, M. Chia, S. Gaur, A. Sondhi, M. Rodriguez-Lorenc, K. Lanoue, B. Chandiwana, D. Nusch, A.